Winslow Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-75
Closed -$7K 89
2018
Q4
$7K Sell
75
-7
-9% -$654 ﹤0.01% 81
2018
Q3
$8K Sell
82
-63
-43% -$5.83K ﹤0.01% 78
2018
Q2
$12K Sell
145
-21
-13% -$1.75K ﹤0.01% 73
2018
Q1
$13K Sell
166
-16
-9% -$1.32K ﹤0.01% 69
2017
Q4
$15K Sell
182
-53
-23% -$4.25K ﹤0.01% 73
2017
Q3
$18K Sell
235
-72
-23% -$5.98K ﹤0.01% 65
2017
Q2
$27K Sell
307
-97
-24% -$8.18K ﹤0.01% 65
2017
Q1
$33K Sell
404
-151
-27% -$11.8K ﹤0.01% 66
2016
Q4
$40K Sell
555
-180
-24% -$14.1K ﹤0.01% 66
2016
Q3
$64K Buy
+735
New +$64K ﹤0.01% 141
2016
Q1
Sell
-4,652,116
Closed -$358M 149
2015
Q4
$358M Sell
4,652,116
-284,732
-6% -$21.4M 1.28% 37
2015
Q3
$330M Buy
4,936,848
+248,076
+5% +$18.3M 1.2% 37
2015
Q2
$347M Buy
+4,688,772
New +$358M 1.15% 37

Other funds holding MDT

Winslow Capital Management's MDT Position: Q1 2019 in Review

Winslow Capital Management sold out of Medtronic (MDT) in Q1 2019, closing a stake of 75 shares — an estimated $7K sold.

Winslow Capital Management first reported a position in MDT in Q2 2015 and held it in 13 quarters. The position peaked at $358M in Q4 2015. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • Winslow Capital Management reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
  • Winslow Capital Management sold 75 Medtronic shares in Q1 2019, an estimated $7K.
  • Winslow Capital Management first reported a position in Medtronic in Q2 2015 and held it in 13 quarters.
  • Winslow Capital Management's Medtronic position peaked at $358M in Q4 2015.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on Winslow Capital Management's 13F filing for Q1 2019, filed 14 May 2019.